CNS Pharmaceuticals, Inc. Common Stock

CNSPNASDAQ • USD
2.89 USD
↘ 0.73 (20.17%)AT CLOSE (03:59 PM EST)
2.99
↗ 0.10 (3.46%)
POST MARKET (AS OF 03:59 PM EST)
Post Market
AS OF 03:59 PM EST
2.99
↗ 0.10 (3.46%)
🔴Market: CLOSED

CNS Pharmaceuticals, Inc. Common Stock (CNSP) is currently trading at $2.89. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.70
High?$3.70
Low?$2.89
Prev. Close?$3.62
Volume?18.1K
Avg. Volume?13.4K
VWAP?$3.34
Rel. Volume?1.35x
Bid / Ask
Bid?$2.90 × 700
Ask?$4.79 × 100
Spread?$1.89
Midpoint?$3.84
Valuation & Ratios
Market Cap?4.2M
Shares Out?1.5M
Float?1.4M
Float %?98.3%
P/E Ratio?N/A
P/B Ratio?0.23
EPS?-$11.43
Dividend?0.00%
Ex-Dividend?N/A
RelatedPTPI
News
Profile
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Employees
8
Market Cap
4.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-11-08
Address
2100 WEST LOOP SOUTH
HOUSTON, TX 77027
Phone: 1-800-946-9185
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.75Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.11%Low
Short Interest?1.6K
Days to Cover?1.0
Free Float1.4M
Avg Daily Volume23.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?5.86Strong
Quick Ratio?5.86Strong
Cash Ratio?5.35Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
0.23CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
3
-91.8%WEAK▾
ROA?
S&P
3
-76.1%WEAK▾
Cash Flow & Enterprise
FCF?$-13442115
Enterprise Value?$-15761412
Fundamentals ratios updated end of day